Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

Pfizer

Overview

Provide pre-approval single patient Expanded Access (Compassionate Use) of Etrasimod for patients.

In Expanded Access, treating physicians are the Sponsors. Expanded Access requests from treating physicians may be submitted to www.pfizercares.com. Availability will depend on location and country.

Study Type

EXPANDED_ACCESS

Conditions

Colitis, Ulcerative

Interventions

EtrasimodDRUG

tablets

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Patient must be intolerant, have a contraindication or had inadequate response to at least 3 therapies available for Ulcerative Colitis (UC) in this country or provide a rationale of why therapy was not used.

Central Contacts

PfizerCares

CONTACT

PfizerCares@Pfizer.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.